Web Results

openjurist.org/753/f2d/208/thompson-medical-company-inc-v-pfizer-inc

Thomas C. Morrison, New York City (Eugene Gelernter, Patterson, Belknap, Webb & Tyler, Stanley M. Grossmann, New York City, Pfizer Inc., of counsel), ..... [ The] strength of the mark, the degree of similarity between the marks, the proximity of the products, the likelihood that the prior owner will bridge the gap, actual ...

law.justia.com/cases/federal/appellate-courts/ca1/11-1904/11-1904-2013-04-03.html

Kaiser Foundation Health Plan and Kaiser Foundation Hospitals (together, Kaiser), Aetna, Inc. and Guardian Life Insurance Company (Guardian) filed a coordinated complaint against Pfizer, Inc. and Warner-Lambert Company ( together, Pfizer). The coordinated plaintiffs asserted violations of, inter alia, the Racketeer ...

law.justia.com/cases/federal/appellate-courts/ca7/17-2056/17-2056-2018-01-19-0.html

Jan 19, 2018 ... Rodney Guilbeau v. Pfizer Inc., No. 17-2056 (7th Cir. 2018) case opinion from the US Court of Appeals for the Seventh Circuit.

media.ca1.uscourts.gov/pdf.opinions/11-1904P-01A.pdf

Apr 3, 2013 ... not required, given the mechanisms by which Pfizer's marketing plan operated. As Judge Posner stated in the Bridge case, after remand: "The doctrine of proximate cause . . . protects the ability of primary victims of wrongful conduct to obtain compensation . . . ." BCS Servs., Inc. v. Heartwood 88, LLC, 637 ...

law.justia.com/cases/federal/appellate-courts/ca7/17-2056/17-2056-2018-01-19.html

Jan 19, 2018 ... Testosterone replacement drugs have been FDA-approved prescription drugs for more than 60 years. In recent years, manufacturers have found a new market: older men. Numerous lawsuits were filed against manufacturers alleging that the drugs increase health risks. Cases alleging that the ...

caselaw.findlaw.com/us-1st-circuit/1626690.html

The arguments presented in Kaiser and in another related appeal in which we issue an opinion today, Harden Manufacturing Co. v. Pfizer, Inc., No. 11–1806 ( 1st Cir ..... reliance on Pfizer's misrepresentations, direct reliance is not an element of proximate cause in a private RICO claim predicated on mail fraud. See Bridge v.

www.courtlistener.com/opinion/2446520/pfizer-inc-v-ranbaxy-laboratories-ltd

Dec 16, 2005 ... This action was brought by Plaintiffs, Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company, LLC and .... This compound has a backbone of two rings joined by a bridge, designated as "X." The five-membered ring on the left contains a nitrogen atom designated as ...

courts.delaware.gov/Opinions/Download.aspx?id=245720

v. ) ) PFIZER, INC.,. ) ) Defendant. ) Submitted: May 19, 2016. Decided: August 31 , 2016. Corrected: September 1, 2016. MEMORANDUM OPINION ... “Trust”).3. The Trust owns 500 shares of Defendant Pfizer, Inc. (“Pfizer”), which is ..... plaintiffs failed to bridge is providing any evidence permitting even an inference that the ...

mcir.usc.edu/cases/2000-2009/Pages/vargaspfizer.html

Shade v. Hous. Auth. of New Haven, 251 F.3d 307, 314 (2d Cir.2001). The burden of demonstrating the absence of any genuine dispute as to a material fact rests with the moving party. Adickes v. S.H. Kress & Co., 398 U.S. 144, 157, 90 S. Ct. 1598, 26 L.Ed.2d 142 (1970); Grady v. Affiliated Cent., Inc., 130 F.3d 553, 559 (2d ...